Lithium therapeutic drug monitoring is the safety backbone of one of psychiatry's most effective medications. Lithium has a narrow therapeutic index: the gap between a dose that stabilises mood and one that causes ataxia, confusion or seizures is smaller than for almost any other psychotropic. A few milligrams of renal retention — from an NSAID, a dehydration bug, or a simple prescription change — can push a stable patient into toxicity.
This guide covers everything an MRCPsych, RANZCP or USMLE candidate needs on lithium blood levels: target ranges for acute and maintenance treatment, the 12-hour trough technique, the drugs and illnesses that raise or lower levels, the full monitoring schedule, and the toxicity picture examiners love. You get a level-to-action table, a sick-day high-yield box, and the four questions trainees ask most.
Why lithium requires blood level monitoring
Lithium is a monovalent cation handled almost entirely by the kidneys — it is filtered freely and reabsorbed in the proximal tubule alongside sodium, so any factor that changes renal sodium handling changes lithium clearance in parallel. There is no receptor-level ceiling on its effect: plasma concentration tracks clinical response and toxicity closely, which is exactly why dosage is titrated to a measured level, not to a fixed milligram target.
Two consequences follow. First, bioavailability and clearance vary several-fold between individuals at the same oral dose — absorption is complete but distribution into total body water dilutes levels, and renal function declines with age. Second, the therapeutic window is genuinely narrow, so monitoring is not a formality: it is the dosing instrument.
Targets to memorise (per local protocol, which always takes precedence): acute mania is commonly treated at 0.8–1.2 mmol/L, while long-term maintenance sits at 0.6–0.8 mmol/L. Some services accept the lower end of the acute range for maintenance in older adults or for partial responders on combined treatment — but the acute 0.8–1.2 / maintenance 0.6–0.8 split is the pair examiners ask for. Levels above roughly 1.5 mmol/L are generally considered toxic territory, with severe toxicity typically described above 2.0 mmol/L, though symptoms can appear at lower levels in chronic users.
Structured revision notes and spaced-repetition decks for mood-disorder pharmacology live in Preppsy's concept library — lithium targets and interactions are high-frequency flashcard material.
Timing the level: the 12-hour trough
Draw lithium levels exactly 12 hours after the last dose — always at trough. Lithium's elimination half-life in healthy adults is roughly 12–24 hours (longer in older patients and in renal impairment), so a level drawn at the wrong point in the dosing interval is uninterpretable: too early and you read a peak as a plateau, too late and you falsely reassure yourself about a subtherapeutic dose.
The practical sequence matters. For a patient on twice-daily lithium, ask them to take their usual evening dose, then attend the next morning for a trough sample. Record the exact times of the last dose and the draw. Steady state takes about 5 half-lives — typically 4–5 days — so sample at least that long after any dose change, and never interpret a level taken before steady state as a stable result.
Standardise the schedule across your service: same lab, same timing convention, same notation, so serial levels are genuinely comparable rather than a patchwork of differently timed samples.
What raises and lowers lithium levels
The classic level-raisers are three drug classes plus volume depletion: NSAIDs, thiazide diuretics, and ACE inhibitors (and ARBs) each reduce lithium clearance through different renal mechanisms — prostaglandin inhibition, sodium depletion driving proximal lithium reabsorption, and angiotensin-mediated effects on renal haemodynamics. Combined, they account for a striking share of lithium toxicity admissions. Dehydration does the same job without a prescription: vomiting, diarrhoea, fever, and prolonged hot weather all concentrate lithium.
Level-lowering factors are classically sodium status and clearance: a high-salt diet or intravenous saline promotes lithium excretion (with the flip side that abrupt sodium depletion retains lithium), while caffeine and theophylline are commonly reported to increase clearance — the exact magnitude is debated, but the direction of effect is fair exam territory.
Metronidazole, certain diuretics (loop and thiazide), and new renin–angiotensin drugs are recurring interaction traps. Whenever a medication is added to a patient on lithium, the reflex should be: check the interaction, review the dose, and recheck the level at steady state.
Reading the result: level-to-action guide
| Clinical situation | Expected level | Action |
|---|---|---|
| Stable maintenance phase (12h trough) | 0.6–0.8 mmol/L | Continue current dose; recheck on schedule |
| Acute mania, active titration | 0.8–1.2 mmol/L | Titrate to clinical response within range |
| Subtherapeutic with breakthrough symptoms | Below 0.6 mmol/L | Check timing and adherence first, then consider dose increase |
| Toxic range or toxicity signs | Typically ≥1.5 mmol/L | Withhold lithium, assess urgently, hydrate, recheck levels |
| New NSAID, thiazide or ACEi started | Expect a rise | Recheck the trough at steady state; consider dose reduction |
Note that symptoms and the number can disagree: a chronically elevated level may be tolerated better than an acutely rising one, and toxicity signs warrant action regardless of the figure on the printout. Always pair the number with the clinical examination — gait, tremor, cognition, hydration.
The wider monitoring package: beyond the lithium level
Lithium monitoring is not just a lithium level. Before starting, and then periodically, the standard battery covers:
- Renal function — urea, electrolytes, creatinine and eGFR, because lithium can cause nephrogenic diabetes insipidus and, with long-term use, chronic tubulointerstitial changes. Ask about polyuria and polydipsia at every review.
- Thyroid function — TSH, because lithium inhibits thyroid hormone release and synthesis; hypothyroidism is common and treatable, and it masquerades as relapse.
- Calcium and parathyroid — lithium-associated hyperparathyroidism and hypercalcaemia are less famous but routinely screened.
- Weight and metabolic review at each contact.
Typical cadence (per local protocol): baseline tests before the first dose, then lithium levels and bloods approximately 3-monthly once the dose is stable, commonly relaxing to 6-monthly for established, adherent patients — with an extra level after any dose change, new interacting drug, or intercurrent illness. Older patients and those with renal impairment are monitored more frequently.
Sick-day rule
Stop lithium during vomiting, diarrhoea or significant dehydration, restart only when eating and drinking normally, and recheck a 12-hour trough before resuming the full dose. Remember the classic triple level-raiser: NSAID + thiazide + ACE inhibitor. Any patient on lithium — and any exam candidate — should be able to recite this unprompted.
Recognising lithium toxicity
Toxicity is a clinical diagnosis supported by a level. The classic progression runs from coarse tremor, gastrointestinal upset (vomiting, diarrhoea), ataxia and dysarthria, through confusion and drowsiness, to seizures, coma and — in severe cases — death. Fine physiological tremor is common at therapeutic doses; a tremor that becomes coarse, or any new gait disturbance, is the bedside warning sign that should trigger an immediate level.
Management follows a simple ladder: withhold lithium, assess hydration and renal function, start IV fluids if indicated, and repeat levels every 2–4 hours until clearly falling. Severe toxicity (encephalopathy, seizures, renal failure, or levels broadly above 2.0 mmol/L with clinical features) requires urgent nephrology input and often haemodialysis — lithium is dialysable, and waiting is not an option.
Practical edge cases
Missed doses: take the forgotten dose as soon as remembered unless the next dose is due — never double up. Patients should know that a single missed dose rarely causes trouble, but repeated misses followed by a "catch-up" binge does.
Pregnancy: lithium is associated with Ebstein's anomaly, but the absolute risk remains low and the relationship is less steep than older texts implied. Decisions are individualised against relapse risk — abrupt discontinuation carries its own danger, and an unplanned pregnancy warrants urgent specialist review rather than panic stopping. Renal clearance falls across pregnancy, so third-trimester levels need closer surveillance; follow your perinatal service's protocol.
Older adults: lower GFR means lower doses and a lower target within the maintenance range, with falls and cognition watched closely.
Key takeaways
- Targets: acute mania 0.8–1.2 mmol/L, maintenance 0.6–0.8 mmol/L — always per local protocol.
- Timing is everything: levels are a 12-hour trough, taken at steady state (≥4–5 days after a dose change).
- The level-raisers: NSAIDs, thiazides, ACE inhibitors/ARBs, plus dehydration — and the sick-day rule stops lithium until hydration recovers.
- Monitor the whole patient: renal function, TSH, calcium/parathyroid and weight, not just the lithium number — typically 3-monthly until stable, often 6-monthly once established.
- Toxicity is clinical: coarse tremor, ataxia, vomiting, confusion — withhold lithium, hydrate, recheck levels every 2–4 hours, escalate early.
Lithium therapeutic drug monitoring ultimately reduces to three habits — trough timing, interaction vigilance, and the sick-day rule — and mastering them protects both patients and exam scores. Build exam-ready fluency in lithium levels, interactions and toxicity with Preppsy's RANZCP preparation tracks, which drill exactly this material in exam format.
Frequently asked questions
What lithium level is therapeutic?
Commonly 0.8–1.2 mmol/L during acute mania treatment and 0.6–0.8 mmol/L for long-term maintenance, measured as a 12-hour trough and interpreted per local protocol. Levels around 1.5 mmol/L and above are generally considered toxic territory, though clinical signs always outrank the number.
How often should lithium levels be checked?
After a level confirms stability: approximately every 3 months while the dose is settling, often relaxing to every 6 months for established, adherent patients on unchanged doses. Recheck sooner after any dose change, new interacting medication, intercurrent illness, or emerging symptoms such as tremor, polyuria or confusion.
What drugs increase lithium levels?
The classic trio is NSAIDs, thiazide diuretics and ACE inhibitors (plus ARBs) — all reduce lithium clearance and can precipitate toxicity, especially with dehydration. Loop diuretics and metronidazole are further traps. Conversely, high sodium intake or IV saline promotes excretion, while caffeine and theophylline are reported to lower levels.
Why does lithium therapeutic drug monitoring use a 12-hour trough?
Because lithium's elimination half-life is roughly 12–24 hours, a sample drawn 12 hours after the last dose reflects true steady-state concentration; earlier samples catch the absorption peak and overestimate exposure. Drawing at the same point every time makes serial results comparable, which is what dose titration depends on.
Cover image: “p_lithium” by Unsplash contributor (Unsplash License (attribution not required)) via unsplash.
